Viewing Study NCT02657434


Ignite Creation Date: 2025-12-25 @ 2:32 AM
Ignite Modification Date: 2026-03-27 @ 1:30 PM
Study NCT ID: NCT02657434
Status: COMPLETED
Last Update Posted: 2023-11-21
First Post: 2016-01-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132)
Sponsor:
Organization: